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ABSTRACT Connexin43 (Cx43) has an important role in skeletal homeostasis, and Cx43 gene 
(Gja1) mutations have been linked to oculodentodigital dysplasia (ODDD), a human disorder 
characterized by prominent skeletal abnormalities. To determine the function of Cx43 at 
early steps of osteogenesis and its role in the ODDD skeletal phenotype, we have used the 
Dermo1 promoter to drive Gja1 ablation or induce an ODDD mutation in the chondro-osteo-
genic linage. Both Gja1 null and ODDD mutant mice develop age-related osteopenia, primar-
ily due to a progressive enlargement of the medullary cavity and cortical thinning. This phe-
notype is the consequence of a high bone turnover state, with increased endocortical 
osteoclast-mediated bone resorption and increased periosteal bone apposition. Increased 
bone resorption is a noncell autonomous defect, caused by exuberant stimulation of osteo-
clastogenesis by Cx43-deficient bone marrow stromal cells, via decreased Opg production. 
The latter is part of a broad defect in osteoblast differentiation and function, which also re-
sults in abnormal structural and material properties of bone leading to decreased resistance 
to mechanical load. Thus Cx43 in osteogenic cells is a critical regulator of both arms of the 
bone remodeling cycle, its absence causing structural changes remindful of aged or disused 
bone.
INTRODUCTION
After embryonic development, the skeleton undergoes continuous 
remodeling during adult life to ensure biomechanical integrity, reju-
venate aging bone, and repair injuries. Bone remodeling is orches-
trated by bone-resorbing cells—osteoclasts—and bone-forming 
cells—osteoblasts—as well as osteocytes, which are embedded into 
the mineralized tissue. In addition to endocrine, paracrine, and au-
tocrine factors, direct cell–cell communication via gap junctions is an 
important mechanism by which bone cells coordinate their activi-
ties. Abundant gap junctions are present between osteocytic pro-
cesses, between osteocytes and osteoblasts on the bone surface, 
and among osteoblasts (Doty, 1981; Palumbo et al., 1990). Gap 
junctions are arrays of hexameric transmembrane channels, called 
connexons, formed by protein subunits called connexins. When two 
connexons are in register on opposing cells, an aqueous conduit is 
formed between two cells—a gap junction channel—which allows 
cell-to-cell diffusion of ions, metabolites, and small signaling mole-
cules (Goodenough et al., 1996). Connexons can also exist as indi-
vidual channels, not paired with apposing connexons, thus function-
ing as large transmembrane channels (Goodenough and Paul, 
2003).
At least three connexins are present in bone cells, each provid-
ing unique permeability, ion selectivity, and electric conductance. 
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osteoblasts in vitro alters only expression of late differentiation 
genes (McLachlan et al., 2008). These abnormalities are insufficient 
to explain the whole ODDD phenotype, raising the possibility that 
the ODDD mutants may interfere with normal Cx43 function at ear-
lier phases of osteoblast differentiation or via other mechanisms.
In this study, we have used the Dermo1/Twist2 (DM1) promoter 
to drive Cre expression (DM1-Cre) and obtain an early but selective 
Gja1 ablation in the chondro-osteogenic lineage (Yu et al., 2003). 
We have also used DM1-Cre mice to induce an ODDD mutation 
selectively in chondro-osteogenic cells. Dermo1/Twist2 is expressed 
at E9.5 in mesodermal tissues (Li et al., 1995), and during endocron-
dral ossification is present in condensed mesenchyme from which 
chondrocytes and osteoblasts are derived (Yu et al., 2003). This ge-
netic approach allows examination of the role of Cx43 at early stages 
of osteogenic cell differentiation starting at an early embryologic 
stage, up to skeletal adulthood.
RESULTS
DM1;Cre-mediated Gja1 deletion in bone cells
As postnatal Dermo1/Twist2 expression has not been fully charac-
terized, we first assessed gene recombination in DM1;Gja1−/fl (cKO) 
adult animals. Cx43 immunoreactive bands were barely detectable 
in cKO whole-bone protein extracts of 1-mo-old mice, whereas they 
were intense in the Gja1fl/wt (WTfl) extracts (Figure 1A). Conversely, 
bands corresponding to β-galactosidase (β-gal) were detected only 
in cKO but not in WTfl extract (Figure 1A), consistent with effective 
LacZ/Gja1 gene replacement in mutant mice. Gja1 deletion was 
also confirmed by positive β-gal staining of tibia sections from 
1-mo-old mice. Whereas no staining was observed in sections from 
WTfl littermates (Figure 1B, a’–c’), in cKO sections, specific β-gal 
staining was observed in cells lining the endocortical surface and in 
the periosteum, in cells slightly away from the endosteal bone sur-
face, and in osteocytes (Figure 1Bd’). However, very little if any 
β-gal staining was observed in cells on trabecular surfaces or in tra-
becular osteocytes (Figure 1Be’), and no staining was present in 
growth plate chondrocytes (Figure 1Bf’). Because DM1-Cre activity 
had been reported in both the growth plate and trabecular bone 
(Yu et al., 2003), we mated DM1-Cre mice with ROSA26 mice to 
determine the field of postnatal DM1-Cre expression. Clear β-gal 
staining was observed in cortical osteoblast and osteocytes (Figure 
1Bg’) but also in trabecular osteoblasts (Figure 1Bh’) as well as 
growth plate chondrocytes (Figure 1Bi’), suggesting that lack of 
β-gal-positive cells in trabecular bone and growth plates of cKO 
mice most likely represents very low levels of Gja1 expression, 
rather than lack of Cre activity. Importantly, LacZ activity persisted in 
cortical bone at least up to 6 mo of age but disappeared by 12 mo 
(Supplemental Figure S1). Long-term persistence of recombined 
cells may reflect postnatal expression of DM1 or a long life cycle of 
the originally recombined chondro-osteogenic precursor cells and 
their progeny. Thus DM1-Cre mice represent a good model of se-
lective gene inactivation in the chondro-osteogenic lineage during 
the first 6 mo of postnatal life.
Delayed mineralization and low bone mass in cKO  
and cODDD mice
All genotypes from both mating schemes were obtained at the ex-
pected Mendelian frequency and all were viable. Whole-mount 
alizarin red/alcian blue staining of newborn mice revealed only mi-
nor dysmorphisms in cKO (Figure 2A), specifically a hypoplastic skull 
with smaller parietal and interparietal bones and smaller mandible. 
There was also a modest reduction in chest cavity due to short ribs 
and slightly shorter tibias and femurs. Newborn DM1;Gja1+/fl(G138R) 
Connexin43 (Cx43) is the most abundant, and multiple lines of evi-
dence have established an important role for Cx43 in skeletal 
development and for the function and survival of osteoblasts and 
osteocytes (see Stains and Civitelli, 2005; Civitelli et al., 2008, for 
review). In particular, germline ablation of Gja1, the gene encoding 
for Cx43, results in delayed endochondral and intramembranous 
ossification, osteoblast dysfunction, and craniofacial abnormalities 
(Lecanda et al., 2000). Because of the perinatal lethality of the ger-
mline mutation, tissue-specific Gja1 ablation models have been 
developed. We have previously reported that conditional Gja1 ab-
lation driven by a fragment of the Col1A1 promoter, which ex-
presses in committed osteoblasts, results in accrual of a low peak 
bone mass and an attenuated response to the anabolic effects of 
parathyroid hormone, the consequence of an osteoblast defect 
(Chung et al., 2006). In subsequent studies, we have also shown 
that these mice have enlarged diaphyses and thin cortices of the 
long bones, decreased bone strength, as well as an attenuated 
anabolic response to mechanical load (Grimston et al., 2006, 2008). 
On the other hand, others have reported that Gja1 ablation in more 
mature osteoblasts and osteocytes using the Bgalp promoter 
causes no abnormalities in bone mass and does not prevent gluco-
corticoid-induced bone loss. However, it precludes the effect of 
bisphosphonates on apoptosis (Plotkin et al., 2008), decreases cor-
tical bone strength, and causes structural abnormalities similar to 
Gja1 deletion in less mature osteoblasts (Bivi et al., 2009).
Further proof of the critical role of Cx43 in skeletal biology is 
provided by the identification of Gja1 mutations as the cause of the 
autosomal dominant disorder oculodentodigital dysplasia (ODDD), 
characterized by multi-organ but primarily skeletal abnormalities, 
with syndactyly of the hands, craniofacial dysmorphisms with cranial 
hyperostosis, and broad tubular bones (Loddenkemper et al., 2002; 
Paznekas et al., 2003; Kjaer et al., 2004). Two Gja1 mouse mutants 
have been described with skeletal phenotypes closely resembling 
the human disease, including syndactyly and craniofacial malforma-
tions (Flenniken et al., 2005; Dobrowolski et al., 2008). These animal 
models have also disclosed additional aspects of ODDD that are 
unknown or unreported in humans, in particular generalized os-
teopenia and cortical thinning, which could heavily impact on frac-
ture risk and morbidity in ODDD patients.
Despite significant progress on Cx43 skeletal biology, a number 
of key questions remain unanswered. Accumulated in vivo data 
suggest that Cx43 may be important at early steps of osteogene-
sis, perhaps at the time of osteogenic commitment from undiffer-
entiated precursors. Lack of reliable strategies to induce selective 
gene ablation in osteogenic precursors has so far precluded test-
ing this hypothesis in vivo. Although osteogenic lineage defects 
are evident in Cx43-deficient mice, these defects alone cannot ex-
plain all the phenotypic features produced by Gja1 ablation in dif-
ferentiated osteoblasts, specifically, the widened diaphyses of long 
bones (Grimston et al., 2008) and lack of sensitivity to skeletal me-
chanical unloading (Grimston, Goldberg, Watkins, Brodt, Silva, and 
Civitelli, unpublished data), both of which point to a bone resorp-
tion abnormality. Aside from in vitro studies suggesting a role of 
Cx43 in osteoclast function (Ransjo et al., 2003; Matemba et al., 
2006), bone resorption has not been analyzed in Cx43-deficient 
animals. Furthermore, although ODDD mutations are loss-of-func-
tion and dominant negative for wild-type Cx43 (Roscoe et al., 2005; 
Gong et al., 2007), germline or conditional Gja1 ablation in bone-
forming cells does not exactly phenocopy ODDD, lacking primarily 
the craniofacial malformations. This implies a more complex patho-
biology of Cx43 mutations in the cranium relative to the axial and 
appendicular skeleton. Finally, introduction of ODDD mutants in 
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Cross-sectional analysis of the femoral diaphysis confirmed a sta-
tistically significant larger total tissue area in both cKO (Figure 3, C 
and D; Supplemental Figure S3) and cODDD mice (Figure 3, I and J; 
Supplemental Figure S3). Marrow area was also increased in both 
mutant mice (Supplemental Figure S3, A and C), though the differ-
ences were larger in the cKO than in the cODDD (43 ± 5% vs. 30 ± 
6% relative to WT, respectively). Cortical thickness was significantly 
decreased in both cKO (41 ± 11% of WTfl) and cODDD mice (20 ± 
7% of WTod) (Figure 3, E and K). Accordingly, the calculated cross-
sectional moment of inertia was significantly increased in the Cx43 
cKO compared with WTfl (Supplemental Figure S3, B and D), sug-
gestive of a greater resistance to mechanical strain in the anterior/
posterior direction. However, direct assessment of resistance to 
load, in a three-point bending test to failure, produced rather the 
opposite results, as ultimate force to failure was lower in cKO com-
pared with WT bones (Supplemental Figure S3E). Although the dif-
ferences were not significantly different, most cKO bones bent in 
half without breaking. Because of this unexpected outcome, we also 
assessed yield force, a point at which further load will cause perma-
nent deformation. This measurement was significantly lower in the 
cKO compared with WTfl (Figure 3F). Similar trends were obtained 
with the cODDD bones, although the differences against WTod 
were not statistically significant (Figure 3L and Supplemental Figure 
S3F). Unlike the Cx43 cKO bones, all the bones from the cODDD 
mice did break in the three-point bending test.
Changes in bone formation rates in cKO mice
Because the skeletal phenotypes of cKO and cODDD mice were 
similar, from this point on we present data for the cKO mice only, as 
(cODDD) mice exhibited only skull hypomineralization, without the 
dysmorphic features of cKO mice (Figure 2B). At 1 mo of age, skulls 
of cKO mice were still significantly hypomineralized, as shown by 
μCT, with hypoplastic parietal, interparietal, and occipital bones 
relative to control littermates (Figure 2C), whereas cODDD skulls 
appeared normally mineralized though slightly smaller than control 
littermates at this age (Figure 2D).
Whole-body bone mineral density (BMD) monitored by dual-
energy x-ray absorptiometry (DXA) up to 1 yr of age revealed that 
both Cx43 cKO and cODDD mice were significantly osteopenic 
relative to their respective WT littermates (Figure 2, E and F). This 
low bone mass phenotype was evident at 1 mo of age and persisted 
until 10 mo in both cKO and cODDD groups. The largest differences 
in BMD (∼40%) were observed at younger ages, in both mutant 
groups, with a tendency toward partial recovery after 4 mo of age, 
and 8–12% difference remaining at 12 mo of age in both groups.
Altered bone structure in Gja1 mutants
Structural analysis was performed by μCT in femurs of 3-mo-old ani-
mals postmortem. Macroscopically, femurs of both cKO (Figure 3A) 
and cODDD mice (Figure 3G) were ∼10% shorter in both mutants, a 
significant difference in both cases (Figure 3, B and H), and in both 
cases there was an evident tubulation of the femoral shaft, with 
larger medullary cavity. However, no differences in bone volume/
tissue volume or other trabecular structural parameters were ob-
served in either cKO or cODDD femurs relative to their controls 
(Supplemental Figure S2). Accordingly, static histomorphometric anal-
ysis of cKO bone sections revealed no change in trabecular osteoblast 
or osteoclast numbers per bone surface (Supplemental Figure S2).
FIGuRE 1: Cre-mediated replacement of Gja1. (A) Western blot analysis of whole-bone protein extracts from 3-mo-old 
mice showing strong expression of Cx43 in WTfl extracts and barely detectable immunoreactivity in cKO extracts. LacZ/
Gja1 gene replacement was confirmed by the presence of β-gal immunoreactive bands only in cKO protein extracts.  
(B) β-gal-stained tibia sections of 1-mo-old mice showing specific β-gal staining present in the cKO but not the WTfl tibia 
sections. In the cKO bones, specific β-gal staining was observed in cells lining the endocortical surface, the periosteum, 
and in osteocytes (d’–arrows); however, very little β-gal staining was present in the trabeculae (e’), and none in the 
growth plate chondrocytes (f’). Comparative sections from 1-mo-old DM1;ROSA26 mice showing β-gal staining in cells 
lining the endocortical surface and osteocytes (g’), trabecular osteoblasts (h’), and growth plate chondrocytes (i’).
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surface (Figure 4, B and C). To determine 
the overall impact of this shift of bone for-
mation from the endosteum to the perios-
teum, we measured serum osteocalcin lev-
els, a biochemical marker of bone formation. 
Significantly higher (>40%) serum osteocal-
cin was detected in Cx43-deficient mice 
relative to WTfl (Figure 4D), suggesting an 
exuberant periosteal bone formation in the 
face of decreased bone formation at the en-
dosteal surface.
Altered cortical bone matrix and 
hypomineralization in cKO mice
The decreased bone strength of Gja1 mu-
tant bones, in spite of an increased geomet-
ric moment of inertia, implies an abnormal-
ity in the material properties of mutant 
bones. Using a Masson’s trichrome stain, we 
excluded an increased osteoid thickness in 
cKO bones, thus ruling out osteomalacia as 
a potential cause of the decreased bone 
strength (Figure 5A). Interestingly, the cell 
layer on the periosteal surface was more 
prominent in cKO than in WTfl sections, 
consistent with increased osteoblast activity 
on the periosteum. Low-magnification cross-
sections of the femur confirmed the larger 
size, increased marrow area, and thinner 
cortex and also revealed increased cortical 
porosity in the Cx43 cKO bones, with large 
areas of the cortex undergoing a process of 
spongiosation (Figure 5B). Analysis of tibial 
cortical sections under polarized light after 
picrosirius red staining revealed more disor-
ganized birefringence, especially on the pe-
riosteal surface of cKO sections, reflective of 
disorganized collagen fibers and an appear-
ance of woven bone (Figure 5C). Quantifica-
tion of the birefringence pattern revealed 
that fiber orientation in the WTfl bones clus-
tered around 90 degrees, as expected; 
wheareas in the cKO bone, collagen fiber 
orientation was highly variable and spread 
across the whole range (Figure 5D). Further 
quantification of the degree of disorder of 
collagen bundles revealed that enthropy 
was 3.98 ± 0.57 in cKO, compared with 
2.90 ± 0.024 in WTfl (P < 0.05), respectively, 
about a 40% difference. On the basis of 
such abnormalities in collagen fiber organi-
zation, we measured the abundance of gene 
products known to be involved in extracellular collagen processing, 
using RNA extracted from femurs from which the bone marrow had 
been removed. Interestingly, lysyl oxidase (Lox) mRNA was signifi-
cantly reduced in Cx43 cKO mice (∼57%) compared WTfl mice, 
whereas procollagen lysyl hydroxylase (Plod) and prolyl 3-hydroxy-
lase (P3HA4) were unchanged (Figure 5E). By μCT, mineral density in 
the cKO cortical bone was significantly reduced (−9 ± 2%) relative to 
WTfl (Figure 5F). Despite decreased lox mRNA, we found no major 
abnormality in collagen cross-linking in cKO bones but rather a de-
crease in collagen mRNA abundance (not shown). Fourier transform 
they exhibit more severe phenotypic changes. Representative fluo-
rescent micrographs of calcein-labeled longitudinal sections of cor-
tical bone show a dramatic difference in the size and distribution of 
double labels. Whereas in the WTfl, double labels were only seen in 
the endocortical surface, in the mutant bones, double labels were 
abundant on the periosteal surface, more than in the endosteum 
(Figure 4A). Accordingly, dynamic indices of bone formation (BFR/
BS and MAR) calculated from the growth plate to mid-diaphysis of 
the femur were significantly reduced on the endosteal surface of 
cKO bones, whereas they were strikingly increased on the periosteal 
FIGuRE 2: Low bone mass and delayed mineralization in cKO and cODDD mice. (A) Alizarin red 
and alcian blue stained newborn whole mounts showing malformed, hypoplastic cranial vault 
and smaller thoracic cage in cKO compared with WTfl littermates. (B) Skull hypomineralization 
but no dysmorphic features are seen in cODDD newborn mice compared with WTod littermates. 
(C) MicroCT reconstructions of skulls from 1-mo-old cKO mice showing hypoplastic parietal, 
interparietal, and occipital bones compared with WTfl litermates; but (D) normal mineralization 
in cODDD skulls compared with WTod. (E) Whole-bone mineral density, monitored by DXA at 
monthly intervals is significantly lower in cKO and (F) cODDD relative to their comparative WT 
littermates up to 4 mo of age, with a trend toward partial recovery at later time points  
(*, P < 0.05 for Gja1 mutants vs. comparative WT, 2-way ANOVA; n = 10).
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performed CFU assays to determine whether the number of stromal 
cell precursors was also affected by Gja1 deletion. Intriguingly, the 
number of CFU-fibroblast, an index of stromal uncommitted precur-
sors, was significantly increased in the cKO relative to WTfl bone 
marrow (Figure 6, D and E). Even more surprisingly, the number of 
CFU-osteoblast, an index of osteogenic precursors, was also in-
creased in the mutant animals (Figure 6, F and G). Finally, cell prolif-
eration rate was almost fourfold higher in cKO than in WTfl bone 
marrow stromal cells (Figure 6H).
Increased osteoclastogenesis and bone resorption  
in cKO mice
Bone marrow cavity expansion, a feature common to both cKO and 
cODDD mice, implies increased endocortical bone resorption. Con-
sistent with this hypothesis, we found the number of endocortical 
TRAP+ osteoclasts per bone perimeter to be three- to fourfold 
higher in cKO bones than in WTfl (Figure 7, A and B). Serum levels 
of C-terminal telopeptides of type I collagen, a biochemical marker 
of bone resorption, were significantly higher in cKO than in WTfl 
mice, confirming that the increased endocortical osteoclast number 
reflects increased bone resorption (Figure 7C).
Because Gja1 ablation in this cKO model occurs specifically 
in cells of the osteoblast lineage, we determined whether the 
infrared spectroscopy (FTIR) analysis of bone samples from the KO 
animals suggested that cKO femurs are less mineralized relative to 
WTfl, and the mineral appeared less mature (Supplemental Figure 
S4), although these differences were not significant.
Abnormal osteoblast differentiation and function  
in cKO mice
To investigate the cellular and molecular mechanisms leading to the 
phenotype of Cx43-deficient mice, we profiled gene expression in 
cortical bone cells of mutant and wild-type mice using real-time 
quantitative PCR. Cortical bone extracts (excluding the bone mar-
row, but including the periosteum) confirmed a greater than 80% 
decrease in Gja1 expression (Figure 6A), consistent with Gja1 re-
combination in vivo (see Figure 1). There was no difference in Runx2 
mRNA abundance; but other osteoblastic genes, all down-stream of 
Runx2, were down-regulated in cKO bones relative to WTfl, includ-
ing Osx (42%), Alpl (31%), and Col1A1 (41%), although OPN and 
BSP mRNA were unaffected (Figure 6A). Furthermore, mRNA abun-
dance for osteocyte genes Dmp1 and Sost was also significantly 
reduced in cKO (42% and 62%, respectively; Figure 6B). However, 
the number of osteocytes per cortical surface area was not different 
between cKO mice and WTfl (Figures 5A and 6C). Because DM-1 
induces Gja1 ablation early in the chondro-osteogenic lineage, we 
FIGuRE 3: Altered bone structure and strength in Gja1 mutants. (A) MicroCT (μCT) reconstructions of femurs from 
1-mo-old WTfl and cKO mice showing shorter, tubular femoral shafts with larger medullary cavities. (B) Femur length is 
significantly reduced in the cKO relative to their littermate WT controls. (C) Cross-sections of femurs at middisphysis by 
μCT revealing a wider cortical bone section and marrow cavity of cKO femurs relative to WTfl. (D) Tissue area is 
significantly higher and (E) cortical thickness is significantly lower in cKO compared with WTfl. (F) Yield force, measured 
using a three-point bending test, is reduced relative to WTfl. (G) μCT reconstructions of femurs from 1-mo-old WTod 
and cODDD mice. (H) Femur length is significantly reduced in cODDD mice relative to their littermate WT controls.  
(I) Cross-sections of femurs at middisphysis by μCT revealing a wider cortical bone section and marrow cavity of cODDD 
femurs relative to WTod. (J) Tissue area is significantly higher and (K) cortical thickness is significantly lower in cODDD 
compared with WTod. (L) Yield force is not significantly different in cODDD, compared with WTod (*, P < 0.05, vs. WT; 
t-test for unpaired samples, n = 5).
Volume 22 April 15, 2011 Cx43 regulates bone formation/resorption | 1245 
DISCUSSION
These studies demonstrate that ablation of 
Gja1 or replacement of one wild-type Gja1 
allele with a mutant linked to ODDD in 
chondro-osteoprogenitor cells causes a high 
bone turnover phenotype with increased 
periosteal bone formation, but abnormal 
osteoblast function and indirect endocorti-
cal osteoclast activation. This leads to age-
dependent cortical bone expansion, cortical 
thinning, and deposition of abnormal bone 
tissue. Thus Cx43 controls both arms of 
bone remodeling via the osteoblast.
In previous work, we have ablated Gja1 
in committed osteoblasts and osteocytes 
and found that these mice are osteopenic 
and have functionally defective osteoblasts 
(Chung et al., 2006), widened diaphysis of 
long bones, and decreased bone strength 
(Grimston et al., 2008). Here, using the DM1 
promoter to obtain a broader and earlier 
Gja1 ablation, we observe a similar but more 
severe phenotype, as well as developmen-
tal abnormalities, such as hypoplastic, hy-
pomineralized skulls, smaller thoracic cavi-
ties, and shorter limbs. Such dyspmorphic 
features are similar to those observed in 
germline Gja1 null mice (Lecanda et al., 
2000). At variance with our previous obser-
vations (Chung et al., 2006), we found very 
low, if any, expression of LacZ in trabecular 
bone cells of cKO mice. The reasons for 
such discrepancy are unclear but could be 
related to either low Gja1 expression in tra-
becular bone or lower efficiency of Cre ac-
tivity on the Gja1 allele than on the ROSA26 
reporter allele. Interestingly, in mice where Gja1 was deleted using 
the Bglap promoter, the phenotype is also restricted to cortical 
bone (Plotkin et al., 2008; Bivi et al., 2009). Hence larger diaphyseal 
cross-sectional area and cortical thinning are the most consistent 
phenotypic changes present in adult Gja1 cKO mice, now reported 
in three difference genetic models. Similar cortical abnormalities are 
seen in cODDD mice and were also evident in Gja1Jrt/+ mice, a mu-
tant with a phenotype closely resembling ODDD (Flenniken et al., 
2005), further proving that modeling of cortical architecture is the 
main function of Cx43 in adult bone.
Our studies show that this phenotype is the result of a complex 
mechanism involving both arms of the bone remodeling cycle. Cor-
tical bone expansion is primarily due to accelerated endocortical 
bone resorption, leading to widening of the medullary cavity, which 
is only partially compensated for by an exuberant periosteal bone 
apposition resulting in a larger periosteal perimeter but thinner cor-
tices. Earlier in vitro studies have postulated a role of Cx43 in osteo-
clast function (Ransjo et al., 2003; Matemba et al., 2006). However, 
our genetic modification excludes osteoclasts, and the coculture 
studies establish that the exuberant osteoclastogenesis is entirely 
dependent on Cx43-deficient osteoblast-supporting cells, which 
produce an abnormally low abundance of Opg, a key inhibitor of 
osteoclast differentiation. Further evidence that an abnormal OPG/
RANKL balance is a key mechanism of the Gja1 cKO phenotype is 
provided by the finding that addition of exogenous osteoclasto-
genic factors, M-CSF and RANKL, to the cocultures offsets the 
increased osteoclast number reflects an indirect effect of the 
mutant osteoblast. First we verified that bone marrow–derived 
macrophages (used as osteoclast precursors) from both WTfl 
and cKO mice produced similar numbers of osteoclasts when 
grown in the presence of M-CSF and RANKL (Figure 7, D and 
E). We also verified by Western blot analysis that Gja1 ablation 
does not occur in the osteoclast lineage of cKO mice, as both 
cKO and WTfl macrophages and multinucleated TRAP+ cells 
express Cx43 (Figure 7F). Next we examined expression of os-
teopotegerin (Opg) and Rankl, two key osteoclast regulators 
produced by osteoblasts. Whereas expression of Rankl mRNA 
was unaltered in cKO mice, the abundance of Opg mRNA, an 
inhibitor of osteoclastogenesis, was significantly down-regulated 
in cKO relative to WTfl mice (Figure 7G). We then tested the 
osteoclastogenic potential of wild-type and mutant osteoblastic 
cells by coculturing bone marrow–derived stromal cells with 
macrophages isolated from either cKO or WTfl mice. When 
stromal cells derived from WTfl mice were used to support in 
vitro osteoclastogenesis, similar numbers of osteoclasts formed 
regardless of the osteoclast precursor genotype. However, when 
either cKO or WTfl macrophages were cocultured with cKO 
stromal cells, a fourfold higher number of multinucleated TRAP+ 
osteoclasts were obtained (Figure 7, H and I). Thus it is an 
abnormality in the stromal/osteoblast lineage that determines 
the increased osteoclastogenesis observed in Cx43-deficient 
mice.
FIGuRE 4: Altered cortical bone formation in cKO mice. (A) Fluorescence micrographs of 
calcein labels on the cortical surfaces of WTfl and cKO femurs at 1 mo of age. Double label is 
seen only on the endocortical surface of the WTfl bone, whereas abundant double label is seen 
on the periosteal surface and to a lesser extent on the endosteum of cKO bone. (B) Bone 
formation rate and (C) mineral apposition rate are decreased on the endosteal surface in cKO 
bones, whereas they are both significantly higher on the periosteal surface of mutant mice 
relative to WTfl controls (*, P < 0.05, t-test for unpaired samples, n = 4). (D) Serum osteocalcin 
levels, from 1-mo-old mice, are significantly increased in the cKO relative to WTfl (*, P < 0.05, 
t-test for unpaired samples, n = 7–8).
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difference in osteoclastogenesis between 
WTfl and cKO cells.
The increased periosteal bone apposi-
tion detected in cKO long bones contrasts 
with decreased endosteal bone formation, 
also present in Gja1 ablated mice driven by 
the Col1A1 promoter (Chung et al., 2006; 
Grimston et al., 2008), and accounts for the 
progressive diaphyseal cross-section expan-
sion, perhaps representing a compensatory 
reaction to increased endosteal bone ero-
sion. The mechanism leading to the en-
dosteal-to-periosteal bone formation shift 
remains to be elucidated, though our data 
suggest a possible link to reduced expres-
sion of Sost, an inhibitor of Wnt signaling 
(Krishnan et al., 2006). Notably, Sost-defi-
cient mice exhibit cortical thickening and 
increased tissue area with increased pe-
riosteal and endosteal bone apposition (Li 
et al., 2008; Lin et al., 2009). Diaphyseal ex-
pansion in cKO mice is not present at birth 
but develops with age, and may reflect an 
impaired ability of Cx43-deficient animals to 
adapt to environmental factors. Cx43-defi-
cient mice are less sensitive to anabolic me-
chanical load (Grimston et al., 2008) and 
skeletal unloading (Grimston et al., unpub-
lished data); and Cx43 has been implicated 
in mechanotransduction, primarily in osteo-
cytes (Cherian et al., 2005; Genetos et al., 
2007). This loss of sensitivity to mechanical 
stimuli may be the fundamental mechanism 
by which Cx43 loss leads to age-dependent 
changes in cortical bone. Intriguingly, scle-
rostin-deficient mice are also insensitive to 
in vivo mechanical skeletal unloading (Lin 
et al., 2009), reinforcing the hypothesis 
that Cx43 may regulate adaptive responses 
to mechanical stimuli via modulation of 
sclerostin production.
Not only is cortical bone thinner in the 
cKO, the quality of the bone tissue is also 
abnormal, with disorganized collagen fi-
bers, increased porosity, and decreased 
mineralization. All these factors may explain 
the reduced bone strength and stiffness 
FIGuRE 5: Abnormal cortical bone properties in cKO mice. (A) At 1 mo of age, Goldner 
trichrome stain show thinner cKO cortices relative to WTfl, but no abnormal osteoid. Also note 
the prominent osteoblast layer in the periosteum (black arrow) and endosteum (white arrow) in 
cKO sections. (B) Low-magnification Goldner trichrome-stained cross-sections showing increased 
cortical porosity and larger cross-sections in cKO bone relative to WTfl. (C) Birefringence of 
picrosirius red stained cortical sections show more collagen disorganization and a woven bone 
aspect in cKO relative to WTfl, especially on the periosteal side. (D) Collagen fiber orientation 
was quantitated by measuring the angle of extinction of polarized light in picrosirius red stained 
sections. Whereas collagen fiber orientation 
clusters around 90 degrees in the WTfl, there 
is a wide, uneven spread of collagen fiber 
orientation across the whole range (n = 4). 
(E) Quantitative real-time PCR of femoral 
bone (without bone marrow) RNA extracts, 
revealing lower abundance of Lox mRNA, but 
unchanged Plod and P3HA4 mRNA in cKO 
relative to WTfl. (F) Cortical bone mineral 
density (gHA/cc) measured by μCT showing a 
significant reduction in the cKO relative to 
WTfl (*, P < 0.05 vs. WTfl, t-test for unpaired 
samples; n = 4–6).
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Runx2. Because Gja1 is ablated early in the chondro-osteogenic 
lineage, before Runx2 expression, these results indicate that 
Cx43 regulates progression of osteoblast differentiation at the 
Runx2-Osx transition, resulting in down-regulation of most 
downstream osteoblast genes consistent with previous findings 
(Lecanda et al., 2000; Chung et al., 2006). Interestingly, Cx43 
enhances Runx2 phosphorylation, DNA binding activity, and 
Runx2-mediated gene transcription (Lima et al., 2009). Osteo-
cyte-specific genes, Dmp1 and Sost, are also down-regulated in 
the cKO and may be part of this osteoblastic defect. However, 
cKO bone marrow stromal cells (BMSCs) exhibit significantly 
higher proliferative capacity, likely resulting in the increased num-
ber of bone marrow uncommitted precursors and osteoprogeni-
tors. Higher proliferative activity may also explain the increased 
number of periosteal cells and the increased periosteal bone for-
mation rate.
despite the increased geometric moment of inertia of the larger 
cKO diaphyses. Whereas increased porosity underlies enhanced 
bone resorption, analysis of the material properties of cKO bones 
did not reveal major qualitative defects in either the mineral or 
organic phase. The emerging picture is that of a hypomineralized, 
woven, and immature bone, which might be the consequence of 
accelerated remodeling and inefficient matrix production response 
by Cx43-deficient osteoblasts. Alternatively, the accelerated pe-
riosteal bone formation (and endosteal bone resorption) might 
represent a mechanism to increase bone strength in response to 
this defective bone matrix in cKO mice. Regardless of whether the 
increased cortical turnover is the cause or a consequence of the 
abnormal material properties of cKO bones, a primary osteoblast 
defect is the cause of the entire phenotype.
Many osteoblast gene products are down-regulated in the 
cKO in addition to Opg, including Osx, Bglap, and Alpl, but not 
FIGuRE 6: Abnormal osteoblast differentiation and function in cKO mice. (A) Quantitative real-time PCR on RNA 
extracts from 3-mo-old femurs after bone marrow removal. Data are normalized to Cphn and expressed as mRNA 
abundance relative to WTfl bones. Many, though not all osteoblast genes are down-regulated in cKO bones.  
(B) Quantitative real-time PCR on cortical bone reveals significantly lower Dmp1 and Sost mRNA abundance in cKO 
bones. (C) The number of osteocyte per cortical area, assessed in Masson trichrome-stained, 1-mo-old sections is not 
different between WTfl and cKO femurs. (D) Unfractionated, adherent bone marrow cells were isolated, grown for 14 d 
at different seeding densities, and stained with Giemsa for CFU-F analysis, as detailed in Materials and Methods. (E) At 
each seeding density, there is a significantly higher CFU-F number (colonies with >50 cells) in cKO than in WTfl cultures. 
Each well represents 1 of 24 replicates at the corresponding seeding densities. (F) Bone marrow cells were similarly 
isolated, but cultured in mineralizing medium for 21 d, before alizarin red staining. (G) The percentage of wells that 
mineralized was used as an index of CFU-O, and this percentage is higher in cKO than in WTfl at each seeding density. 
Each group of nine wells is representative of each of the three seeding densities used. (H) Unfractionated, adherent 
bone marrow cells were assayed for BrdU incorporation over a 6-h period, using a chemiluminescent detection system. 
BrdU incorporation is about threefold higher in cKO than in WTfl cultures (*, P < 0.05, vs. WTfl; t-test for unpaired 
samples; n = 3 or 4).
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Introduction of the G138R Gja1 muta-
tion, linked to ODDD, in chondo-osteogenic 
cells recapitulates the most relevant skeletal 
features of cKO mutants. This phenotype is 
caused by replacement of a single wild-type 
allele, and because Gja1 heterozygous null 
mice have a normal skeleton (Lecanda 
et al., 2000; Chung et al., 2006), the G138R 
Gja1 mutant is indeed dominant-negative 
for Cx43, as postulated by in vitro studies 
(Roscoe et al., 2005). Furthermore, as this 
mutant has also been shown to enhance he-
michannel function (Gong et al., 2007; 
Dobrowolski et al., 2008), our results argue 
against the hypothesis that hemichannel ac-
tivity is involved in bone turnover modula-
tion. Severe whole-body osteopenia and 
larger but thinner femoral diaphyses were 
also observed in other ODDD mouse mod-
els (Flenniken et al., 2005; Dobrowolski 
et al., 2008). Intriguingly, osteopenia has 
never been described in patients with 
ODDD, who are typically reported as 
having hyperostosis of the cranial vault 
(Loddenkemper et al., 2002; Paznekas 
et al., 2003; Kjaer et al., 2004). These dis-
crepancies may reflect species-related dif-
ferences, though bone mass measurements 
have never been reported in ODDD pa-
tients. However, broad tubular bones are 
frequently observed in ODDD patients, and 
this feature may indeed reflect the cortical 
bone expansion and attendant high bone 
remodeling emerging from this study.
In summary, Cx43 modulates both arms 
of the bone-remodeling cycle in adult bones 
via cell autonomous and noncell autono-
mous actions, causing indirect activation of 
endocortical osteoclasts and resulting in 
age-dependent cortical bone expansion 
and cortical thinning. This is not effectively 
compensated by increased periosteal bone 
formation, as the material properties of the 
newly formed bone are abnormal, resulting 
in compromised bone strength. Such 
changes are remindful of those that occur in 
aging and disuse osteoporosis.
MATERIAL AND METHODS
Transgenic mice
For conditional Gja1 ablation, a mouse 
strain harboring a mutant “floxed” Gja1 al-
lele (Gja1flox) (Theis et al., 2001) was mated 
to mice expressing Cre under control of the 
DM1 promoter (DM1-Cre) (Yu et al., 2003), 
resulting in Cre-mediated replacement of 
the entire Gja1 reading frame with the LacZ 
reporter cassette. To avoid potential effects 
of Cre activation in the parental germ line 
(Theis et al., 2001), and following a previ-
ously described strategy (Chung et al., 
FIGuRE 7: Increased osteoclastogenesis and bone resorption in cKO mice. (A) Sections 
of cortical bone from 1-mo-old mice showing endocortical TRAP+ cells of both WTfl and 
cKO bones (arrows). (B) The number of osteoclasts (multinucleated TRAP+ cells) on the 
endocortical surface is significantly higher in cKO than in WTfl. (C) Serum C-terminal 
telopeptides of type I collagen is also increased in cKO relative to WTfl. (D) Osteoclast 
precursors (macrophages) isolated from either cKO or WTfl bone marrow were cultured in 
96-well plates for 5 d in the presence of M-CSF and RANKL. (E) No differences in the 
number of TRAP+, multinucleated osteoclasts were observed between genotypes. 
(F) Macrophages (Mac) isolated from either cKO or WTfl bone marrow and cultured  
for 5 d in the presence of M-CSF, and osteoclasts (OC), obtained by further incubation of 
macrophages with M-CSF and RANKL, were lysed for immunoblotting. Cx43 expression 
was lower in mature osteoclasts relative to macrophages in both genotypes with no 
difference between genotypes. (G) The abundance of Opg mRNA, assessed by  
real-time PCR in extracts from femurs (without bone marrow), is lower in cKO  
relative to WTfl, whereas Rankl mRNA is not different. (H) Osteoblasts and osteoclast 
precursors isolated from either cKO or WTfl bone marrow were cocultured in 24-well 
plates for 7 d in medium supplemented with vitamin D and dexamethasone, for 
development of TRAP+, multinucleated osteoclasts. (I) Osteoblasts from WTfl mice 
support the same number of osteoclastic cells regardless of the genotype of the 
osteoclast precursors, whereas when cKO osteoblasts are used, a higher number of 
osteoclast form regardless of the osteoclast precursor genotype (*, P < 0.05,  
vs. WTfl, t-test for unpaired samples, n = 5-8; †, P < 0.05 vs. WT OB; Tukey test;  
n = 4).
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−80°C for later assays. Bone samples were prepared as previously 
described with some modifications (Chung et al., 2006). Quantita-
tive histomorphometry was performed as detailed elsewhere 
(Castro et al., 2004; Grimston et al., 2006). Some undecalcified sec-
tions were stained with a Goldner’s modified trichrome technique, 
which was also used on thick (80 μm) sections to visualize cortical 
porosity (Hirano et al., 2000).
Some decalcified bone samples were processed for β-gal stain-
ing as detailed (Chung et al., 2006), with the addition of 100 mM 
galactose to the staining solution to quench nonspecific staining. 
To study collagen fiber orientation, paraffin sections were stained 
in 0.1% picrosirius red solution, destained in 1% (v/v) acetic acid, 
and counterstained with hematoxylin. The samples were visualized 
on a polarized light microscope (Olympus BX51P; Olympus, To-
kyo, Japan), and images were analyzed as previously described 
(Thomopoulos et al., 2006).
Bone marrow stromal progenitor cells
We used a modification of a previously described method (Castro 
et al., 2004; Di Benedetto et al., 2010). The entire marrow cavity 
of the shafts (femora and tibiae) of 3-mo-old mice was flushed 
by removing one of the epiphyses and centrifuging the bone at 
10,000 rpm for 15 s. After hemolysis in a red blood cell lysis buffer 
(Roche Applied Science, Mannheim, Germany), the material was re-
suspended in αMEM (Mediatech, Herndon, VA) and filtered through 
a 70-μm cell strainer. Cells were resuspended in αMEM containing 
20% fetal calf serum (FCS) and antibiotics and plated in 96-well tis-
sue culture plates at different seeding densities for determination of 
colony forming unit-fibroblast (CFU-F) or -osteoblast (CFU-O). For 
CFU-F, cells were seeded in αMEM supplemented with 20% FCS. 
The number of CFU-F was determined after 14 d of culture by fixa-
tion in ethanol and staining with Giemsa. Colonies containing more 
than 50 cells were counted. For CFU-O assessment, cells were 
seeded in α-MEM supplemented with 20% FCS, 50 μM ascorbic 
acid, and 10 μM β-glycerophosphate. Cells were cultured for 21 d, 
then fixed in 50% ethanol/18% formaldehyde, and stained for min-
eralized matrix using alizarin red. Wells that stained were counted 
positive for mineralization, and the percentage of the 24 replicate 
wells in each plate that mineralized was calculated for all cell densi-
ties. All CFU experiments were undertaken in triplicate.
Osteoclast cultures
The marrow cavity was flushed as described above. Cells were 
resuspended in αMEM (Mediatech, Manassas, VA) and filtered 
through a 70-μm cell strainer. Cell were resuspended in αMEM 
containing 10% FCS, antibiotics, and 100 ng/ml M-CSF and 
cultured for 5 d, with media being replenished every second 
day. Thereafter, resultant macrophages were released and 3.0 × 105 
cells seeded in a 96-well plate in α-MEM supplemented with 10% 
fetal bovine serum (FBS), 10 ng/ml M-CSF, and 100 ng/ml RANKL. 
Cells were grown for 7 d and then stained for TRAP using the 
Leukocyte Acid Phosphatase kit (Sigma-Aldrich, St. Louis, MO). 
The number of multinucleated, TRAP+ cells was determined as 
index of osteoclastogenesis.
Stromal cell-macrophage cocultures
BMSCs were isolated as described above, resuspended, and cul-
tured in α-MEM supplemented with 10% FCS for 24 h. Nonadherent 
cells, which include macrophages, were removed and replated in a 
separate Petri dish in α-MEM supplemented with 10% FCS that fa-
vors macrophage growth. Adherent cells were cultured for 7 d in 
α-MEM supplemented with 20% FCS to stimulate proliferation of 
2006), we crossed Gja1flox/flox mice with DM1-Cre mice also carrying 
a Gja1 null allele (DM1-Cre;Gja1+/−). These crosses produce, in ap-
proximately equal numbers, Gja1 conditionally deleted mice, DM1-
Cre;Gja1flox/− (cKO), as well as Gja1flox/+ (wild-type equivalent; WTfl), 
Gja1flox/− (heterozygous equivalent), and DM1-Cre;Gja1flox/+ (condi-
tional heterozygous). Since we found that the latter two genotype 
groups have no detectable phenotypic abnormalities, only data 
from cKO and WTfl are reported here.
To induce an ODDD mutation selectively in chondro-osteopro-
genitor cells, we mated DM1-Cre with Gja1flox(G138R)/flox(G138R) mice, a 
kind gift from Klaus Willecke (University of Bonn, Germany). Analo-
gously to the “floxed” Gja1 mutant, Cre-mediated recombination 
in the Gja1flox(G138R) mice removes the wild-type Gja1 allele, replac-
ing it with a Gja1 G138R mutant allele (Dobrowolski et al., 2008). 
These crosses generate conditional heterozygous mutants, DM1-
Cre;Gja1flox(G138R)/+ (cODDD), and wild-type equivalent Gja1flox(G138R)/+ 
(WTod) mice. Because of the gender-specific differences in bone 
structure, male and female mice were analyzed separately, but we 
present data on male mice as similar results were obtained in both 
genders. ROSA26 mice (a generous gift from Henry Kronenberg, 
Harvard University, Boston, MA) were mated with DM1-Cre mice to 
determine the effectiveness of DM1-driven Cre recombination in 
adult mice (Soriano, 1999).
Genotyping was performed by PCR on genomic DNA extracted 
from mouse tails using the HotSHOT method (Truett et al., 2000). 
We used previously described methods to detect the Gja1 null, 
wild-type, floxed alleles (Chung et al., 2006) and Gja1flox(G138R) alleles 
(Dobrowolski et al., 2008), as well as the DM1-Cre (Liu et al., 2002) 
and ROSA26 transgenes (Mao et al., 1999).
All the mouse lines used in this project were developed in a 
mixed C57BL/6-C129/J background, and littermates were used as 
controls. Mice were fed regular chow ad libitum and housed in a 
room maintained at constant temperature (25°C) on a 12-h light and 
12-h dark schedule. All procedures were approved by the Animal 
Studies Committee of Washington University in St. Louis.
Whole body mounts
Newborn mice were stained with alizarin red and alcian blue as pre-
viously described (Chung et al., 2006).
Bone mass and microstructure
Whole-body bone mineral content and BMD were monitored by 
DXA using a PIXImus scanner (GE/Lunar, Madison, WI) under anes-
thesia as previously described (Castro et al., 2004). Analysis of femo-
ral bone structure was performed using a μCT system (μCT 40; 
Scanco Medical AG, Zurich, Switzerland), as also previously de-
scribed (Grimston et al., 2008; Di Benedetto et al., 2010). μCT of 
skulls from 1-mo-old mice were also performed. Skulls were stabi-
lized in 1.5–2.0% agarose gel and scanned using 45 EkVp radiation 
energy at standard resolution (20 μm). About 250 images were used 
for 3D reconstruction.
Bone biomechanics
Mechanical testing in a three-point bending to failure was con-
ducted on femora after μCT scanning as described previously (Di 
Benedetto et al., 2010).
Bone histology and histomorphometry
Mice were labeled twice by injection of calcein (15 mg/kg i.p.; 
Sigma-Aldrich, St. Louis, MO) 7 and 2 d before euthanasia, which 
was performed under light anesthesia by exsanguination through 
dorsal aortic puncture. Blood was collected and the serum stored at 
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10 mM EDTA for 5 min at 37°C. Proteins were separated on 8% 
Tris-glycine SDS gel and transferred to Immobilon membranes 
(Millipore, Billerica, MA). The membrane was probed with antibod-
ies against Cx43 (C6219; Sigma-Aldrich), β-gal (ab616; Abcam, 
Cambridge, MA), and α-tubulin (sc-8035; Santa Cruz Biotechnology, 
Santa Cruz, CA).
FTIR analysis
Femur midshafts from WTflx and cKO animals were collected, soft 
tissues removed, and the bone marrow removed by centrifugation 
and the samples lyophilized. The samples were pulverized and 
studied in transmission mode in KBr pellets using Bucker Vertex 70 
FTIR spectrometer (Millipore, Billerica, MA). The spectra were col-
lected with the resolution of 2 cm−1 with 32 scans collected per each 
spectrum.
Statistical analysis
Groups means were compared by t-test for unpaired samples. Data 
on repeated measures were analyzed by analysis of variance 
(ANOVA). Data were analysed using SigmaPlot Vs11.0 (Systat Soft-
ware GmbH, Germany). All data are expressed as the mean ± SD.
BMSCs. Thereafter, stromal cells and macrophages were released 
from their respective dishes, mixed (3.4 × 105 each), and seeded in 
a 24-well plate in α-MEM supplemented with 10% FBS, 10 nM vita-
min D3, and 100 nM dexamethasone (Wang et al., 2004). These 
cocultures were incubated for 7 d and then stained for TRAP as de-
scribed above.
Cell proliferation
BMSCs were isolated as described above, counted, and seeded in 
α-MEM supplemented with 20% FBS on a black-sided, 96-well tis-
sue culture plate. Twenty-four hours later, the cells were labeled with 
BrdU, and incorporation was quantified using a chemiluminescent 
Cell Proliferation ELISA kit as per manufacturer’s instructions (Roche 
Applied Science, Mannheim, Germany).
Real-time quantitative PCR
Total RNA was extracted from whole bones that had been flushed 
of bone marrow as described above and flash frozen in liquid ni-
trogen. Bones were pulverized using a Braun Mikrodismembrator 
(Sartorius Stedim Biotech S.A., Aubagne, France). Total RNA was 
extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) and fur-
ther purified using Phase-Lock gel tubes (5 Prime, Hamburg, 
Germany) and Qiagen RNA Easy kit (Qiagen, Valencia, CA) as per 
the manufacturer’s instructions. Contaminating DNA was removed 
by RNase-free DNase (Qiagen, Valencia, CA) treatment. mRNA 
was quantified following previously described methods (Stains 
et al., 2003; Mbalaviele et al., 2005), and 1 μg total RNA was 
reverse transcribed using a Superscript VILO cDNA synthesis kit 
(Invitrogen, Carlsbad, CA). Real-time PCR analysis performed in 
an Applied Biosytem 7500 Fast detector system using the SYBR 
green PCR method according to manufacturer’s instruction 
(Applied Biosystems, Foster City, CA). The mean cycle threshold 
value (Ct) from triplicate samples was used to calculate gene ex-
pression, and PCR products were normalized to Cphn levels for 
each reaction. Relative gene expression levels were determined 
as described in User’s Bulletin (P/N 4303859) from Applied Biosys-
tems. Primer sets are detailed in Supplemental Table 1. Taqman 
Gene expression assays (Applied Biosystems) were used for quan-
tification of Dmp1, Lox, Plod, and P3ha4, according to manufac-
turer’s instruction (Applied Biosystems).
Biochemical markers of bone turnover
Serum C terminus Cross-Linked Telopeptides of Type I Collagen 
(CTX) and osteocalcin were measured as indices of bone resorption 
and formation, respectively. For these assays, serum was obtained 
from mice that had been deprived of food and water for 6 h. Analy-
ses were performed by ELISA, using a CTX (RatLaps EIA; Immunodi-
agnostics Systems, Fountain Hills, AZ) and the osteocalcin kit (Mouse 
Osteocalcin EIA Kit; Biomedical Technologies, Stoughton, MA), ac-
cording to the manufacturer’s instructions.
Immunoblotting
Protein extracts were prepared from whole bones that had been 
flushed of bone marrow and processed as described earlier. The 
pulverized bone was incubated in 50 mM Tris, pH 8.0, 150 mM 
NaCl, 2 mM EDTA, 1% Triton-X, 0.1% SDS, 0.5% sodium deoxy-
cholate, 2 mM NaVO4, 10 mM NaF, and protease inhibitors at 4°C 
for 10 min then centrifuged at 12,000 g for 20 min. Total protein 
concentration was measured using the BCA method (Pierce, Rock-
ford, IL) and normalized against extraction buffer. Protein from os-
teoclast cultures was isolated using the same method, after removal 
of adherent stromal cells from six-well cultures by incubation with 
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